(AFRM) Affirm Holdings - Ratings and Ratios
Point-Of-Sale, Installment, Merchant, App, Consumer
EPS (Earnings per Share)
Revenue
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 79.1% |
| Value at Risk 5%th | 115% |
| Relative Tail Risk | -11.45% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.60 |
| Alpha | -9.22 |
| CAGR/Max DD | 1.16 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.363 |
| Beta | 2.413 |
| Beta Downside | 2.479 |
| Drawdowns 3y | |
|---|---|
| Max DD | 57.38% |
| Mean DD | 24.51% |
| Median DD | 23.39% |
Description: AFRM Affirm Holdings December 17, 2025
Affirm Holdings, Inc. (NASDAQ: AFRM) operates a U.S.-based payment network that extends to Canada and other international markets, offering a point-of-sale financing solution, merchant commerce tools, and a consumer-facing app that lets shoppers split purchases into installments.
In FY 2023 the company reported roughly $1.5 billion in revenue and processed about $15 billion in total payment volume, reflecting a year-over-year growth rate near 20 % despite a net loss of $300 million as it invests in technology and expands its merchant base.
The buy-now-pay-later (BNPL) sector is being shaped by a 12 % CAGR in consumer demand, tighter credit conditions from rising interest rates, and intensifying competition from both fintechs and traditional card issuers-all of which directly affect Affirm’s pricing power and merchant adoption rates.
For a deeper quantitative dive into AFRM’s risk-adjusted valuation, you might explore the analytics on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 233.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 2.95 > 1.0 |
| NWC/Revenue: 67.55% < 20% (prev 343.1%; Δ -275.5% < -1%) |
| CFO/TA 0.08 > 3% & CFO 971.6m > Net Income 233.1m |
| Net Debt (6.53b) to EBITDA (917.8m): 7.11 < 3 |
| Current Ratio: 14.61 > 1.5 & < 3 |
| Outstanding Shares: last quarter (348.3m) vs 12m ago 9.44% < -2% |
| Gross Margin: 67.62% > 18% (prev 0.66%; Δ 6696 % > 0.5%) |
| Asset Turnover: 32.00% > 50% (prev 24.90%; Δ 7.10% > 0%) |
| Interest Coverage Ratio: 1.56 > 6 (EBITDA TTM 917.8m / Interest Expense TTM 431.3m) |
Altman Z'' 0.52
| A: 0.20 (Total Current Assets 2.51b - Total Current Liabilities 171.7m) / Total Assets 11.48b |
| B: -0.26 (Retained Earnings -2.98b / Total Assets 11.48b) |
| C: 0.06 (EBIT TTM 674.1m / Avg Total Assets 10.81b) |
| D: -0.37 (Book Value of Equity -3.00b / Total Liabilities 8.18b) |
| Altman-Z'' Score: 0.52 = B |
Beneish M 0.91
| DSRI: 0.03 (Receivables 283.7m/6.29b, Revenue 3.46b/2.52b) |
| GMI: 0.97 (GM 67.62% / 65.71%) |
| AQI: 8.69 (AQ_t 0.73 / AQ_t-1 0.08) |
| SGI: 1.37 (Revenue 3.46b / 2.52b) |
| TATA: -0.06 (NI 233.1m - CFO 971.6m) / TA 11.48b) |
| Beneish M-Score: 0.91 (Cap -4..+1) = D |
ValueRay F-Score (Strict, 0-100) 58.76
| 1. Piotroski: 4.0pt |
| 2. FCF Yield: 2.56% |
| 3. FCF Margin: 22.24% |
| 4. Debt/Equity: 2.41 |
| 5. Debt/Ebitda: 7.11 |
| 6. ROIC - WACC: -5.25% |
| 7. RoE: 7.75% |
| 8. Revenue Trend: 97.60% |
| 9. EPS Trend: 77.67% |
What is the price of AFRM shares?
Over the past week, the price has changed by -3.36%, over one month by -9.37%, over three months by -10.12% and over the past year by +24.54%.
Is AFRM a buy, sell or hold?
- Strong Buy: 11
- Buy: 6
- Hold: 7
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the AFRM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 92.3 | 34.4% |
| Analysts Target Price | 92.3 | 34.4% |
| ValueRay Target Price | 71.6 | 4.2% |
AFRM Fundamental Data Overview January 26, 2026
P/E Forward = 73.5294
P/S = 6.8156
P/B = 7.147
P/EG = 0.555
Revenue TTM = 3.46b USD
EBIT TTM = 674.1m USD
EBITDA TTM = 917.8m USD
Long Term Debt = 7.93b USD (from longTermDebt, last quarter)
Short Term Debt = 12.3m USD (from shortTermDebt, last quarter)
Debt = 7.96b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 6.53b USD (from netDebt column, last quarter)
Enterprise Value = 30.06b USD (23.58b + Debt 7.96b - CCE 1.48b)
Interest Coverage Ratio = 1.56 (Ebit TTM 674.1m / Interest Expense TTM 431.3m)
EV/FCF = 39.08x (Enterprise Value 30.06b / FCF TTM 769.2m)
FCF Yield = 2.56% (FCF TTM 769.2m / Enterprise Value 30.06b)
FCF Margin = 22.24% (FCF TTM 769.2m / Revenue TTM 3.46b)
Net Margin = 6.74% (Net Income TTM 233.1m / Revenue TTM 3.46b)
Gross Margin = 67.62% ((Revenue TTM 3.46b - Cost of Revenue TTM 1.12b) / Revenue TTM)
Gross Margin QoQ = 67.65% (prev 67.72%)
Tobins Q-Ratio = 2.62 (Enterprise Value 30.06b / Total Assets 11.48b)
Interest Expense / Debt = 1.38% (Interest Expense 110.0m / Debt 7.96b)
Taxrate = 2.80% (2.33m / 83.0m)
NOPAT = 655.2m (EBIT 674.1m * (1 - 2.80%))
Current Ratio = 14.61 (Total Current Assets 2.51b / Total Current Liabilities 171.7m)
Debt / Equity = 2.41 (Debt 7.96b / totalStockholderEquity, last quarter 3.30b)
Debt / EBITDA = 7.11 (Net Debt 6.53b / EBITDA 917.8m)
Debt / FCF = 8.49 (Net Debt 6.53b / FCF TTM 769.2m)
Total Stockholder Equity = 3.01b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.16% (Net Income 233.1m / Total Assets 11.48b)
RoE = 7.75% (Net Income TTM 233.1m / Total Stockholder Equity 3.01b)
RoCE = 6.16% (EBIT 674.1m / Capital Employed (Equity 3.01b + L.T.Debt 7.93b))
RoIC = 6.16% (NOPAT 655.2m / Invested Capital 10.64b)
WACC = 11.41% (E(23.58b)/V(31.54b) * Re(14.81%) + D(7.96b)/V(31.54b) * Rd(1.38%) * (1-Tc(0.03)))
Discount Rate = 14.81% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 6.41%
[DCF Debug] Terminal Value 56.59% ; FCFF base≈613.7m ; Y1≈402.9m ; Y5≈183.8m
Fair Price DCF = N/A (negative equity: EV 2.29b - Net Debt 6.53b = -4.24b; debt exceeds intrinsic value)
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: 77.67 | EPS CAGR: 4.94% | SUE: -1.61 | # QB: 0
Revenue Correlation: 97.60 | Revenue CAGR: 28.83% | SUE: 0.55 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.70 | Chg30d=-0.024 | Revisions Net=+2 | Analysts=5
EPS current Year (2026-06-30): EPS=3.03 | Chg30d=-0.079 | Revisions Net=-1 | Growth EPS=+73.6% | Growth Revenue=+25.8%
EPS next Year (2027-06-30): EPS=3.71 | Chg30d=-0.124 | Revisions Net=-1 | Growth EPS=+22.2% | Growth Revenue=+24.6%
Additional Sources for AFRM Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle